
Discussing axSpA: Biologic therapy outcomes in axial spondyloarthritis
Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered how certolizumab pegol reduces anterior uveitis flares ...
15 Maj 21min

Author Interview: Professor Valentino Paci, April 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and am Professor Valentino Paci, Medical researcher specialized in immune-mediated diseases, with a particular focus on spondyloarth...
30 Apr 40min

Discussing RA: Updated EULAR recommendations and next-step strategies after TNF inhibitor failure
Join Professor Iain McInnes and Professor Rieke Alten for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, they will review a paper by Smolen et ...
30 Apr 14min

Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘safety and clinical efficacy of bimekizumab in patient...
14 Apr 16min

Author Interview: Professor Helena Marzo-Ortega, March 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Helena Marzo-Ortega an academic clinician and the Clinical Lead of the multi-award winning Leeds Specialist Spondyloar...
9 Apr 37min

Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper a paper on the malignancy risk in patient...
26 Mars 10min

Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeutic switching drivers
Join Dr Sofia Ramiro and Dr Atul Dheodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the impact of shorter versus longer symptom duration on the e...
19 Mars 33min

Author Interview: Doctor Carlo Tur, February 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor Carlo Tur, from the department of Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University, Erlangen-Nurnbe...
12 Mars 29min




















